ELISA Kit for Heparan Sulfate Proteoglycan (HSPG)

SDC2; HSPG1; SYND2; Fibroglycan; Syndecan 2; Syndecan Proteoglycan 2; Heparan Sulfate Proteoglycan 1,Cell Surface-Associated; Heparan Sulphate Proteoglycan

Specificity

This assay has high sensitivity and excellent specificity for detection of Heparan Sulfate Proteoglycan (HSPG).
No significant cross-reactivity or interference between Heparan Sulfate Proteoglycan (HSPG) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Heparan Sulfate Proteoglycan (HSPG) and the recovery rates were calculated by comparing the measured value to the expected amount of Heparan Sulfate Proteoglycan (HSPG) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 91-105 101
EDTA plasma(n=5) 92-103 98
heparin plasma(n=5) 80-90 86

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Heparan Sulfate Proteoglycan (HSPG) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Heparan Sulfate Proteoglycan (HSPG) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Heparan Sulfate Proteoglycan (HSPG) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 97-104% 78-94% 80-96% 83-93%
EDTA plasma(n=5) 87-95% 87-102% 99-105% 86-96%
heparin plasma(n=5) 78-101% 91-99% 85-93% 78-103%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
TMB Substrate 1×9mL Stop Solution 1×6mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Journal of Applied Pharmaceutical Science Cytotoxic effects of antiglypican-3 against HepG3 cell line Ebscohost: Source
Journal of Reproductive Immunology Fibrinogen, an endogenous ligand of Toll-like receptor 4, activates monocytes in pre-eclamptic patients Pubmed: 24661950
European journal of pharmacology Suramin inhibits hepatic tissue damage in hepatocellular carcinoma through deactivation of heparanase enzyme Pubmed: 24530413
European Journal of Pharmacology Evaluation of antiglypican-3 therapy as a promising target for amelioration of hepatic tissue damage in hepatocellular carcinoma Pubmed:25449037
Shock Impairment of the Endothelial Glycocalyx in Cardiogenic Shock and its Prognostic Relevance Pubmed:25692257
Biomarkers in Medicine Endothelial glycocalyx layer shedding following lung resection pubmed:27643669
Apmis Circulating syndecans during critical illness. pubmed:28256016
Biomedicine & Pharmacotherapy Cytotoxic and partial hepatoprotective activity of sodium ascorbate against hepatocellular carcinoma through inhibition of sulfatase-2 and Pubmed:29669302
Drug Delivery Glioma targeting peptide modified apoferritin nanocage Pubmed:29726297
Anaesthesia Postoperative microcirculatory perfusion and endothelial glycocalyx shedding following cardiac surgery with cardiopulmonary bypass Pubmed: 30687934
Animals Diet Supplementation with a Bioactive Pomace Extract from Olea europaea Partially Mitigates Negative Effects on Gut Health Arising from a Short-Term Fasting Period …
LIFE SCIENCES Heparin prevents in vitro glycocalyx shedding induced by plasma from COVID-19 patients 33781826
Genet Mol Biol A novel mutation in ext2 caused hereditary multiple exostoses through reducing the synthesis of heparan sulfate 34042151
Poultry Science Response of broiler chickens fed diets supplemented with a bioactive olive pomace extract from Olea europaea to an experimental coccidial vaccine?¡­ 33518110
J Gerontol A Biol Sci Med Sci The effect of pre-operative methylprednisolone on postoperative delirium in elderly patients undergoing gastrointestinal surgery: a randomized, double-blind, placebo … 34423832
Catalog No. Related products for research use of Rattus norvegicus (Rat) Organism species Applications (RESEARCH USE ONLY!)
RPA565Ra01 Recombinant Heparan Sulfate Proteoglycan (HSPG) Positive Control; Immunogen; SDS-PAGE; WB.
PAA565Ra01 Polyclonal Antibody to Heparan Sulfate Proteoglycan (HSPG) WB; IHC; ICC; IP.
SEA565Ra ELISA Kit for Heparan Sulfate Proteoglycan (HSPG) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA565Ra Multiplex Assay Kit for Heparan Sulfate Proteoglycan (HSPG) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.